E. Sarmiento

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)

Engineering precision nanoparticles for drug delivery

Monitoring of Immunoglobulin Levels Identifies Kidney Transplant Recipients at High Risk of Infection

Calcineurin Inhibitor Nephrotoxicity

Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation

Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation

The Immunology of Posttransplant CMV Infection

Common variable immunodeficiency: a new look at an old disease

Sarcoidosis

Hospital-Onset Clostridium difficile Infection Among Solid Organ Transplant Recipients

Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review

Immune monitoring post liver transplant

Platelets and the immune continuum

Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis

Adeno-associated virus vector as a platform for gene therapy delivery

The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation

The global burden of IBD: from 2015 to 2025

Effect of hypogammaglobulinemia after lung transplantation: a single-institution study

An International Survey of Cytomegalovirus Prevention and Treatment Practices in Intestinal Transplantation

A Novel COX‐2 Inhibitor Pyrazole Derivative Proven Effective as an Anti‐Inflammatory and Analgesic Drug

Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients

Gut Microbiota in Health and Disease

The ITP syndrome: pathogenic and clinical diversity

Encapsulating an Immunosuppressant Enhances Tolerance Induction by Siglec‐Engaging Tolerogenic Liposomes

Post‐transplant monitoring of NK cell counts as a simple approach to predict the occurrence of opportunistic infection in liver transplant recipients

Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance

Prevalence of Clostridium difficile Infection among Solid Organ Transplant Recipients: A Meta-Analysis of Published Studies

Antibiotic-Associated Diarrhea: Epidemiology, Trends and Treatment

Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation

Decreased Levels of Serum Immunoglobulins as a Risk Factor for Infection After Heart Transplantation

Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study

Hypogammaglobulinemia after heart transplantation: use of intravenous immunoglobulin replacement therapy in relapsing CMV disease

The Potential Impact of Substitutive Therapy With Intravenous Immunoglobulin on the Outcome of Heart Transplant Recipients With Infections

Partial Response to Anti-CD20 Monoclonal Antibody Treatment of Severe Immune Thrombocytopenic Purpura in a Patient with Common Variable Immunodeficiency

Clostridium difficile–associated Diarrhea in Heart Transplant Recipients: Is Hypogammaglobulinemia the Answer?

Simultaneous Monitoring of Cytomegalovirus-Specific Antibody and T-cell levels in Seropositive Heart Transplant Recipients

Humoral and cellular immune monitoring might be useful to identify liver transplant recipients at risk for development of infection

Inhibition of brush border dipeptidase with cilastatin reduces toxic accumulation of cyclosporin A in kidney proximal tubule epithelial cells

Humoral and Cellular Monitoring to Predict the Development of Infection in Crohn's Disease Patients Beginning Treatment with Infliximab

Immunological risk factors for infection after immunosuppressive and biologic therapies

IgG monitoring to identify the risk for development of infection in heart transplant recipients

Evaluation of an immunological score to assess the risk of severe infection in heart recipients

Mannose-Binding Lectin Serum Levels and Pre-Tranplant Genotypes for Personalized Anti-CMV Prophylaxis in Heart Recipients

Restoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post‐transplant antibody deficiency and severe infections

Early intravenous immunoglobulin replacement in hypogammaglobulinemic heart transplant recipients: results of a clinical trial

CMV-Seronegative Heart Recipients Disclose a Lower Immunocompetence Status Before Transplantation in Comparison With Seropositive Patients

Decreased levels of serum complement C3 and natural killer cells add to the predictive value of total immunoglobulin G for severe infection in heart transplant recipients